Today's Clinical Lab

The wait is over! Our November issue is here, spotlighting the latest insights in genetics and genomics! Discover the advances reshaping diagnostics and patient care. Click here to explore the article: https://bit.ly/3As0Vod Which article sparks your curiosity the most? Let us know below! 👇 #Genetics #ClinicalLab #Genomics

What does the FDA’s LDT Final Rule mean for your lab? Join Charles Dunham IV and Nick Diamond on March 5 at 1 PM ET as they break down the key takeaways, potential impacts, and next steps for compliance. Don’t be caught unprepared—gain the insights you need to stay ahead. 📅 Register now: https://bit.ly/40QJBlZ Sponsored by Greenberg Traurig, LLP

Imagine a world where your workflows flow, your data behaves, and efficiency isn't just a dream.  Sounds nice, right? Well, good news—this white paper, sponsored by Sapio Sciences, is here to make that vision a reality! From clunky processes to data bottlenecks, it tackles the key challenges holding your lab back and offers smart solutions to keep you ahead in today’s fast-paced environment. 📖 Download now and future-proof your lab: https://bit.ly/4jJhk9I

💘 Roses are red, viruses mutate, This 13-part series is truly first-rate! 💉🔬 From emerging threats to diagnostic breakthroughs, our Infectious Diseases Trends series covers it all—thanks to our brilliant authors: 💡 Pallavi Upadhyay, PhD, CMPP 💡 Maria Rosales Gerpe, MSc, PhD 💡 Dr. Rodney E Rohde, SV, SM, MB (ASCP), FACSc, 💡 Tyler Radke, MLS(ASCP)CM 💡 C Raina MacIntyre, MBBS, FRACP, FAFPHM, M App Epid, PhD 💡 Jake Moskowitz, DVM, PhD 💡 Guy Regnard, PhD 💡 Morgana Moretti, PhD 💡 Miriam Bergeret, MSc 💡 Carolyn Yanavich, PhD 💘 Because nothing says infectious like a compelling read! Read the full series here: https://bit.ly/432Vx6G

Why settle for the status quo in your lab? Unlock the full potential of your research with proven strategies from our White Paper, courtesy of our collaboration with Thermo Fisher Scientific. It’s time to rethink what’s possible! 🌐 Dive into the insights: https://bit.ly/3ZImrO1

Ever feel like implementing new pathology tech is like assembling furniture without the instructions? 🛠️😵💫  Fear not!  Our 2025 Pathology Implementation Digital Forum is here to help you decode the process, dodge the pitfalls, and optimize your workflow. Join leading experts as they break down real-world case studies, share hard-earned lessons, and explore cutting-edge solutions—all from the comfort of your lab (or couch, we don’t judge). 🗓️ Save your spot now: https://bit.ly/4hRp3AH

Unlock expert insights into clinical lab efficiency! 📘  Dive into our essential eBook, proudly sponsored by bioMérieux, and discover strategies that streamline operations and enhance accuracy.  Ready to transform your lab's approach?  Explore now: https://bit.ly/4dKv27O

👩🔬✨ Celebrating Women in Science! ✨📖 Science doesn’t just happen in the lab—it’s powered by the voices that share discoveries, spark conversations, and keep the clinical world informed.  Today, we’re celebrating the amazing women behind Today's Clinical Lab who bring cutting-edge insights to the scientific community every day! 👏 A huge shoutout to our brilliant team: Miriam Bergeret, MSc, Sierra Foster, Dawn Schaefer, Xandrina Allday, Casine Brown, Jennifer Chalmers, Jennifer Duray, Willow Frost, Karen Tucker, Julia Wolff, Ashleigh Campsall, Danielle Gibbons, Janette Latour, AnnaMaria Vasco, Alisha Vroom, Bibi Campos Seijo, Katrina Carpenter P.Eng, PMP, Emma McFarland, CHRP, Debbie Fraleigh, Lauren Law-Masters, Sonali Parmar, Lu Chen, Doris Huang, Alyx Kloeg, Maggie Mullin, Kristine Tomlinson, and Mandy Karl. 🔬 Whether it’s uncovering industry trends, reporting on breakthroughs, or keeping clinical labs connected, your work makes an impact! 💡💪

It's time to talk rules—but don’t worry, we promise it won’t be as painful as reading the fine print. Join legal experts Charles Dunham IV and Nick Diamond on March 5 at 1 PM ET as they break down the FDA's LDT Final Rule—what it means, what’s next, and how your lab can stay compliant (without losing your sanity). 🔎 Compliance deadlines are coming… do you know where your lab stands? 📅 Register now: https://bit.ly/40QJBlZ

The first patient has been dosed in a Phase 1 trial for OKN-4395—a first-in-class EP2, EP4, and DP1 triple inhibitor taking on solid tumors.  Three targets, one mission: reshaping cancer treatment. 🏥💥 Is this the start of a new era in oncology?  Find out what makes this approach so unique: https://bit.ly/3CvEGyT